ENST00000476772.5:n.430C>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000476772.5(VEGFA):​n.430C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.683 in 1,449,354 control chromosomes in the GnomAD database, including 339,475 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.68 ( 35366 hom., cov: 33)
Exomes 𝑓: 0.68 ( 304109 hom. )

Consequence

VEGFA
ENST00000476772.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1O:1

Conservation

PhyloP100: 1.03

Publications

979 publications found
Variant links:
Genes affected
VEGFA (HGNC:12680): (vascular endothelial growth factor A) This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 6-43770613-C-G is Benign according to our data. Variant chr6-43770613-C-G is described in ClinVar as [Benign]. Clinvar id is 12223.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.706 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VEGFANM_003376.6 linkc.-94C>G 5_prime_UTR_variant Exon 1 of 8 ENST00000672860.3 NP_003367.4 P15692-13

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VEGFAENST00000672860.3 linkc.-94C>G 5_prime_UTR_variant Exon 1 of 8 NM_003376.6 ENSP00000500082.3 P15692-13A0A5F9ZH41

Frequencies

GnomAD3 genomes
AF:
0.682
AC:
103572
AN:
151946
Hom.:
35315
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.675
Gnomad AMI
AF:
0.804
Gnomad AMR
AF:
0.654
Gnomad ASJ
AF:
0.589
Gnomad EAS
AF:
0.596
Gnomad SAS
AF:
0.726
Gnomad FIN
AF:
0.770
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.686
Gnomad OTH
AF:
0.651
GnomAD4 exome
AF:
0.684
AC:
886758
AN:
1297288
Hom.:
304109
Cov.:
57
AF XY:
0.684
AC XY:
436658
AN XY:
638118
show subpopulations
African (AFR)
AF:
0.682
AC:
17853
AN:
26166
American (AMR)
AF:
0.662
AC:
13922
AN:
21040
Ashkenazi Jewish (ASJ)
AF:
0.584
AC:
12178
AN:
20870
East Asian (EAS)
AF:
0.578
AC:
17211
AN:
29752
South Asian (SAS)
AF:
0.729
AC:
49096
AN:
67388
European-Finnish (FIN)
AF:
0.764
AC:
24470
AN:
32024
Middle Eastern (MID)
AF:
0.614
AC:
2896
AN:
4718
European-Non Finnish (NFE)
AF:
0.684
AC:
712359
AN:
1041272
Other (OTH)
AF:
0.680
AC:
36773
AN:
54058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14388
28777
43165
57554
71942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18792
37584
56376
75168
93960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.682
AC:
103677
AN:
152066
Hom.:
35366
Cov.:
33
AF XY:
0.686
AC XY:
51010
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.675
AC:
28021
AN:
41496
American (AMR)
AF:
0.654
AC:
10000
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.589
AC:
2044
AN:
3470
East Asian (EAS)
AF:
0.596
AC:
3052
AN:
5124
South Asian (SAS)
AF:
0.726
AC:
3507
AN:
4828
European-Finnish (FIN)
AF:
0.770
AC:
8148
AN:
10586
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.686
AC:
46619
AN:
67964
Other (OTH)
AF:
0.649
AC:
1371
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1759
3518
5278
7037
8796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
824
1648
2472
3296
4120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.632
Hom.:
1917
Bravo
AF:
0.666
Asia WGS
AF:
0.699
AC:
2435
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27648002, 25992764, 23957473, 25328912, 22993299, 15338501, 11978667, 24205329, 23007030, 16142870, 19653005, 23353010, 10930302, 15963467) -

Microvascular complications of diabetes, susceptibility to, 1 Other:1
May 01, 2002
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
18
DANN
Benign
0.93
PhyloP100
1.0
PromoterAI
-0.075
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2010963; hg19: chr6-43738350; API